Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ipilimumab in advanced melanoma: reports of long-lasting responses.
Farolfi A, Ridolfi L, Guidoboni M, Nicoletti SV, Piciucchi S, Valmorri L, Costantini M, Scarpi E, Amadori D, Ridolfi R. Farolfi A, et al. Among authors: amadori d. Melanoma Res. 2012 Jun;22(3):263-70. doi: 10.1097/CMR.0b013e328353e65c. Melanoma Res. 2012. PMID: 22516968
MicroRNAs and dendritic cell-based vaccination in melanoma patients.
de Rosa F, Fanini F, Guidoboni M, Vannini I, Amadori D, Ridolfi R, Ridolfi L, Fabbri M. de Rosa F, et al. Among authors: amadori d. Melanoma Res. 2014 Jun;24(3):181-9. doi: 10.1097/CMR.0000000000000058. Melanoma Res. 2014. PMID: 24638153 Review.
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
Conteduca V, Gurioli G, Rossi L, Scarpi E, Lolli C, Schepisi G, Farolfi A, De Lisi D, Gallà V, Burgio SL, Menna C, Amadori A, Losi L, Amadori D, Costi MP, De Giorgi U. Conteduca V, et al. Among authors: amadori a, amadori d. BMC Cancer. 2018 Dec 19;18(1):1267. doi: 10.1186/s12885-018-5180-1. BMC Cancer. 2018. PMID: 30567527 Free PMC article.
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.
Rocca A, Farolfi A, Maltoni R, Carretta E, Melegari E, Ferrario C, Cecconetto L, Sarti S, Schirone A, Fedeli A, Andreis D, Pietri E, Ibrahim T, Montalto E, Amadori D. Rocca A, et al. Among authors: amadori d. Breast Cancer Res Treat. 2015 Jul;152(1):57-65. doi: 10.1007/s10549-015-3423-2. Epub 2015 May 27. Breast Cancer Res Treat. 2015. PMID: 26012644
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.
Farolfi A, Scarpi E, Rocca A, Mangia A, Biglia N, Gianni L, Tienghi A, Valerio MR, Gasparini G, Amaducci L, Faedi M, Baldini E, Rubagotti A, Maltoni R, Paradiso A, Amadori D. Farolfi A, et al. Among authors: amadori d. Eur J Cancer. 2015 Sep;51(14):1874-81. doi: 10.1016/j.ejca.2015.07.003. Epub 2015 Jul 20. Eur J Cancer. 2015. PMID: 26206258 Clinical Trial.
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.
Milandri C, Polico R, Garcea D, Passardi A, Gardini A, Romeo A, Scarpi E, Rosetti P, Ridolfi L, La Barba G, Ricci M, Amadori D. Milandri C, et al. Among authors: amadori d. Hepatogastroenterology. 2011 Mar-Apr;58(106):599-603. Hepatogastroenterology. 2011. PMID: 21661438
Prospective comparison of prognostic scores in palliative care cancer populations.
Maltoni M, Scarpi E, Pittureri C, Martini F, Montanari L, Amaducci E, Derni S, Fabbri L, Rosati M, Amadori D, Nanni O. Maltoni M, et al. Among authors: amadori d. Oncologist. 2012;17(3):446-54. doi: 10.1634/theoncologist.2011-0397. Epub 2012 Feb 29. Oncologist. 2012. PMID: 22379068 Free PMC article. Clinical Trial.
518 results